Skip to main content
CTNM logo

CTNM · Contineum Therapeutics, Inc. · Analyst Estimates

Track CTNM — free
$14.82 +0.16 (+1.09%) At close · Sep 11
Market Cap
$557.55M
Shares
37.62M

Analyst Estimates

Compare analyst forecasts for Contineum Therapeutics, Inc. across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Only independently verified consensus published through the company's investor-relations sources is available.

Consensus not yet available

Only independently verified consensus published through the company's investor-relations sources is available.

Key facts CIK 1855175 CUSIP 21217B100 13F (30d) 71 filings 71 filers Visit website Investor relations